No Data
No Data
Lanwei Medical (301060.SZ): Zeng Weixiong was elected as the company's Director.
Gelonghui, December 16 - Lanwei Medical (301060.SZ) announced that, after being reviewed and approved by the Board of Directors, Mr. Zeng Weixiong was elected as the chairman of the company, with a term starting from the date of approval at the first meeting of the fourth Board of Directors until the end of the fourth Board of Directors' term.
Express News | This month, 25 listed companies announced that Shareholders had reduced their Shareholding to 5% or below. The next day, Shanghai New World hit the limit down.
Lanwei Medical (301060.SZ): Hailan Group's equity change has reached 5%.
Galunhui December 5th | Lanwei Medical (301060.SZ) announced that the company recently received a "Simple Equity Change Report" issued by shareholder Heilan Group. From November 24, 2022 to December 4, 2024, Heilan Group accumulated sold 19,926,000 shares of the company through the Shenzhen Stock Exchange in a centralized bidding and block trading manner, accounting for 4.98% of the total share capital of the company, and 5.00% of the total share capital after excluding the shares in the company's repurchase special account. After the above-mentioned equity changes, Heilan Group's total number of shares held by the company decreased from 42,900,000 shares to
A-share AI medical concept stocks opened high, with Shanghai Runda Medical Technology and many other stocks hitting the limit up.
On November 25, Gelonghui reported that Shanghai Runda Medical Technology, Lanwei Medical, Edan Instruments, Inc., berry genomics, digital humans, and Lude Medical all surged to their limits in bidding, while Chison Medical Technologies, Guiyang Longmaster Information & Technology, Thalys Medical Technology Group Corporation, and Wonders Information opened significantly higher. In terms of news, the National Medical Insurance Administration stated that in order to support the relatively mature ai-assisted technologies in clinical applications and to prevent additional burden on patients, it has analyzed the potential application scenarios of ai and established 'ai assistance' expansion items in radiological examinations, ultrasound examinations, and rehabilitation projects.
November 13th A-share Investment Lightning Rod: Bona Film Group - several shareholders plan to reduce their shareholding by no more than 3.9754%; Ningbo Runhe High-Tech Materials - shareholders plan to jointly reduce their shareholding by no more than 2.0
Bona Film Group, with multiple shareholders, plans to reduce their shareholding by no more than 3.9754%; Runhe High-Tech Materials' shareholders plan to collectively reduce their shareholding by no more than 2.00%; Lanwei Medical's shareholder, Hailan Group, plans to reduce their shareholding by no more than 2%; Shanghai Sunglow Packaging Technology stated additional investment in Jintaike involving new business areas with uncertain expected returns; Zhengping Road & Bridge Construction received a warning letter from the Qinghai Regulatory Bureau of the China Securities Regulatory Commission; Asia Pacific Network Security received a warning letter from the Jiangsu Regulatory Bureau.
Express News | Summary of shareholding reductions by listed companies on November 12th (table)
No Data